Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia. more
Time Frame | EVH | Sector | S&P500 |
---|---|---|---|
1-Week Return | 2.06% | -2.27% | -0.57% |
1-Month Return | -10.75% | -3.96% | 1.21% |
3-Month Return | -62.21% | -9.7% | 7.57% |
6-Month Return | -49.22% | -3.37% | 11.45% |
1-Year Return | -61.42% | 3.71% | 28.48% |
3-Year Return | -56.96% | 3.8% | 29.52% |
5-Year Return | 47.41% | 39.78% | 90.66% |
10-Year Return | -39.66% | 106.91% | 203.75% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 846.38M | 1.02B | 907.96M | 1.35B | 1.96B | [{"date":"2019-12-31","value":43.1,"profit":true},{"date":"2020-12-31","value":52.06,"profit":true},{"date":"2021-12-31","value":46.23,"profit":true},{"date":"2022-12-31","value":68.84,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 513.06M | 701.37M | 657.55M | 1.04B | 1.50B | [{"date":"2019-12-31","value":34.13,"profit":true},{"date":"2020-12-31","value":46.65,"profit":true},{"date":"2021-12-31","value":43.74,"profit":true},{"date":"2022-12-31","value":68.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 333.32M | 321.06M | 250.41M | 316.58M | 460.47M | [{"date":"2019-12-31","value":72.39,"profit":true},{"date":"2020-12-31","value":69.72,"profit":true},{"date":"2021-12-31","value":54.38,"profit":true},{"date":"2022-12-31","value":68.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 39.38% | 31.40% | 27.58% | 23.42% | 23.45% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":79.74,"profit":true},{"date":"2021-12-31","value":70.03,"profit":true},{"date":"2022-12-31","value":59.46,"profit":true},{"date":"2023-12-31","value":59.54,"profit":true}] |
Operating Expenses | 453.73M | 372.03M | 279.54M | 336.46M | 531.68M | [{"date":"2019-12-31","value":85.34,"profit":true},{"date":"2020-12-31","value":69.97,"profit":true},{"date":"2021-12-31","value":52.58,"profit":true},{"date":"2022-12-31","value":63.28,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (120.41M) | (37.88M) | 30.25M | (59.84M) | (71.21M) | [{"date":"2019-12-31","value":-398.07,"profit":false},{"date":"2020-12-31","value":-125.24,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-197.81,"profit":false},{"date":"2023-12-31","value":-235.42,"profit":false}] |
Total Non-Operating Income/Expense | (217.25M) | (92.87M) | (12.41M) | (79.92M) | (180.14M) | [{"date":"2019-12-31","value":-21725400000,"profit":false},{"date":"2020-12-31","value":-9286600000,"profit":false},{"date":"2021-12-31","value":-1240800000,"profit":false},{"date":"2022-12-31","value":-7992200000,"profit":false},{"date":"2023-12-31","value":-18014300000,"profit":false}] |
Pre-Tax Income | (327.12M) | (337.80M) | (29.80M) | (62.08M) | (202.41M) | [{"date":"2019-12-31","value":-32711600000,"profit":false},{"date":"2020-12-31","value":-33779900000,"profit":false},{"date":"2021-12-31","value":-2980100000,"profit":false},{"date":"2022-12-31","value":-6207700000,"profit":false},{"date":"2023-12-31","value":-20240500000,"profit":false}] |
Income Taxes | (21.54M) | (3.55M) | 483.00K | (43.38M) | (89.36M) | [{"date":"2019-12-31","value":-4458.8,"profit":false},{"date":"2020-12-31","value":-735.61,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-8980.54,"profit":false},{"date":"2023-12-31","value":-18502.07,"profit":false}] |
Income After Taxes | (305.58M) | (334.25M) | (30.28M) | (18.70M) | (113.04M) | [{"date":"2019-12-31","value":-30558000000,"profit":false},{"date":"2020-12-31","value":-33424600000,"profit":false},{"date":"2021-12-31","value":-3028400000,"profit":false},{"date":"2022-12-31","value":-1870100000,"profit":false},{"date":"2023-12-31","value":-11304000000,"profit":false}] |
Income From Continuous Operations | (301.97M) | (334.25M) | (30.28M) | (18.70M) | (113.04M) | [{"date":"2019-12-31","value":-30197100000,"profit":false},{"date":"2020-12-31","value":-33424600000,"profit":false},{"date":"2021-12-31","value":-3028400000,"profit":false},{"date":"2022-12-31","value":-1870100000,"profit":false},{"date":"2023-12-31","value":-11304000000,"profit":false}] |
Income From Discontinued Operations | 1.61M | (6.07M) | (7.32M) | (463.00K) | - | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-376.57,"profit":false},{"date":"2021-12-31","value":-453.63,"profit":false},{"date":"2022-12-31","value":-28.7,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (305.58M) | (334.25M) | (30.28M) | (18.70M) | (113.04M) | [{"date":"2019-12-31","value":-30558000000,"profit":false},{"date":"2020-12-31","value":-33424600000,"profit":false},{"date":"2021-12-31","value":-3028400000,"profit":false},{"date":"2022-12-31","value":-1870100000,"profit":false},{"date":"2023-12-31","value":-11304000000,"profit":false}] |
EPS (Diluted) | (0.73) | (0.21) | 0.02 | 0.91 | 0.88 | [{"date":"2019-12-31","value":-80.22,"profit":false},{"date":"2020-12-31","value":-23.08,"profit":false},{"date":"2021-12-31","value":2.2,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.7,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
EVH | |
---|---|
Cash Ratio | 0.22 |
Current Ratio | 1.04 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
EVH | |
---|---|
ROA (LTM) | 0.73% |
ROE (LTM) | -5.78% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
EVH | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.58 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.42 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
EVH | |
---|---|
Trailing PE | NM |
Forward PE | 10.54 |
P/S (TTM) | 0.53 |
P/B | 1.26 |
Price/FCF | 106 |
EV/R | 0.75 |
EV/Ebitda | 29.93 |
PEG | NM |
Evolent Health Inc (EVH) share price today is $11.38
Yes, Indians can buy shares of Evolent Health Inc (EVH) on Vested. To buy Evolent Health Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in EVH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Evolent Health Inc (EVH) via the Vested app. You can start investing in Evolent Health Inc (EVH) with a minimum investment of $1.
You can invest in shares of Evolent Health Inc (EVH) via Vested in three simple steps:
The 52-week high price of Evolent Health Inc (EVH) is $35. The 52-week low price of Evolent Health Inc (EVH) is $10.82.
The price-to-earnings (P/E) ratio of Evolent Health Inc (EVH) is
The price-to-book (P/B) ratio of Evolent Health Inc (EVH) is 1.26
The dividend yield of Evolent Health Inc (EVH) is 0.00%
The market capitalization of Evolent Health Inc (EVH) is $1.37B
The stock symbol (or ticker) of Evolent Health Inc is EVH